Concepedia

Tal Flieswasser

TF

Statistics

Publications

9

Citations

559

H-Index

9

Active since

2018

Affiliations

Antwerp University Hospital(Current)

University of Antwerp

Ablynx (Belgium)

Argenx (Belgium)

Vrije Universiteit Brussel

Tal Flieswasser is an author at Antwerp University Hospital specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

2018–2024

9

Publications

9

Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells

Jinthe Van Loenhout, Tal Flieswasser, Laurie Freire Boullosa et al. · Cancers · 2019 · 113 citations · Full text

Medicine, Immunology, Oncology +15

Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer

Laurie Freire Boullosa, Jinthe Van Loenhout, Tal Flieswasser et al. · Redox Biology · 2021 · 109 citations · Full text

Medicine, Oncology, Pharmacology +17

IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts

Astrid Van den Eynde, Laura Gehrcken, Tias Verhezen et al. · Journal of Hematology & Oncology · 2024 · 95 citations · Full text

Medicine, Immunology, Oncology +17

Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation

Julie Jacobs, Vanessa Deschoolmeester, Karen Zwaenepoel et al. · OncoImmunology · 2018 · 65 citations · Full text

Medicine, Immunology, Oncology +15

Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method

Tal Flieswasser, Valérie Camara‐Clayette, Alina Danu et al. · Cancers · 2019 · 63 citations · Full text

Medicine, Oncology, Pathology +11

1–5 of 9